Cefexin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefexin

Cefexin is a prescription-only medication containing the active ingredient Cefixime, a semisynthetic antibiotic used to eliminate susceptible bacteria.


Property Description
Active ingredient Cefixime (INN)
Form Tablet, Capsule, Oral Suspension
Pharmacological class beta-Lactam Antibiotic, Third-Generation Cephalosporin
Common use Addressing bacterial infections
Origin Semisynthetic

What Type of Medicine is Cefexin (Cefixime)?

Cefexin is a semisynthetic drug chemically classified as a beta-Lactam antibiotic, belonging specifically to the third-generation cephalosporin group. This classification means it has an inherent advantage in stability against bacterial enzymes that often inactivate older antibiotic types. The advanced chemical structure of Cefixime helps it maintain effectiveness against a broad-spectrum of bacteria, which is a key benefit when selecting treatment. Its use as a third-generation agent is clinically recognized for its efficacy in a range of common bacterial infection scenarios.


Composition and Available Forms of Cefexin

Cefixime is a single active ingredient product designed for oral administration. The medication is available in standard dosage forms, including the tablet, capsule, and a liquid oral suspension. The liquid oral suspension form is a key differentiating feature, often specifically formulated for pediatric patient groups to ensure ease of intake, allowing the drug to be administered accurately across a wider age range.


What is the General Purpose of Taking Cefexin?

The general purpose of Cefexin is to help the body overcome illness by exerting a bactericidal effect, meaning it actively kills susceptible bacteria rather than merely inhibiting their growth. The core mechanism is based on disrupting bacterial cell wall synthesis, a critical process for bacterial survival. This focused antimicrobial role makes Cefexin a mainstay in treating infections where the bacterial cause is confirmed or highly suspected.

Regulatory References

  1. Cefixime - DailyMed - NIH

What side effects are possible with Cefexin?

Possible Side Effects and Safety Information

Cefexin is generally associated with a range of side effects, primarily affecting the gastrointestinal system. The most common adverse reactions reported include diarrhea, nausea, vomiting, dyspepsia, and abdominal pain.

Serious Adverse Reactions and Warnings

Regulatory authorities document several serious and clinically significant adverse reactions that require immediate attention:

  • Hypersensitivity Reactions: Allergic reactions can be severe and life-threatening, ranging from rash and hives to anaphylaxis and severe skin conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Cefexin is contraindicated in patients with a known allergy to it or other cephalosporins, and caution is required for patients with a penicillin allergy due to the risk of cross-hypersensitivity.
  • Gastrointestinal Complications: Like nearly all antibiotics, Cefexin may cause Clostridium difficile-associated diarrhea (CDAD), which can vary from mild diarrhea to fatal colitis. This may occur during treatment or even months after discontinuing the drug.
  • Seizure Potential: Seizures have been reported with cephalosporins, particularly in patients with impaired renal function whose dosage was not properly adjusted.
  • Hematologic Effects: The drug may be associated with a positive direct Coombs' test and, rarely, drug-induced hemolytic anemia.

Safety Considerations

Specific Patient Populations: Patients with renal impairment require cautious use and possible dosage adjustment due to slower removal of the drug from the body. Geriatric patients are also more likely to have reduced kidney function, necessitating monitoring. Trace amounts of Cefexin are excreted in human milk.

Laboratory Interactions: Administration of Cefexin may result in a false-positive reaction for glucose in the urine with certain testing solutions.

Restrictions: The use of Cefexin in the absence of a proven or strongly suspected bacterial infection increases the risk of developing drug-resistant bacteria.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents state that an overdose of Cefexin (Cefixime) may be associated with the risk of severe neurological manifestations. The primary documented concern is the development of encephalopathy, which may include clinical signs such as convulsions (seizures), confusion, impaired consciousness, and movement disorders. These specific neurological symptoms are particularly noted to occur in cases of overdose, especially for patients who also have underlying renal impairment (kidney function disorder).

In the event of a suspected overdose, the official regulatory guidance mandates that individuals must immediately seek emergency medical attention or contact a Poison Control Center. Discontinuation of the drug is required if severe neurological symptoms such as seizures occur.

Management of Cefexin overdose is constrained because no specific antidote exists. Furthermore, regulatory information confirms that the drug is not removed in significant quantities from the body’s circulation through either hemodialysis or peritoneal dialysis. Therefore, official procedures focus on symptomatic and supportive treatment, with gastric lavage noted as a measure that may be indicated.

Therapeutic Uses of Cefexin

Quick Facts: Cefexin Therapeutic Domains

  • Supports management of susceptible respiratory tract infections.
  • Helps address middle ear infections (otitis media).
  • Assists in the treatment of infections of the skin and soft tissues.
  • May be used for certain bone infections and genitourinary tract infections.

Cefexin (referred to as Cephalexin in its generic form) is an established therapeutic agent used to support recovery from various bacterial infections. Its primary role is to aid in the management of infections caused by certain susceptible bacteria in several areas of the body.

Key areas where Cefexin may be beneficial include the treatment of respiratory tract infections, such as those impacting the pharynx. It also supports treatment protocols for otitis media (middle ear infections). Furthermore, Cefexin is indicated for assisting the resolution of skin and soft tissue infections, as well as specific bone infections. It may also be prescribed for genitourinary tract infections, including acute prostatitis, when caused by identified susceptible organisms.

Eligibility and Restrictions for Use

Cefexin's eligibility for use is strictly defined by regulatory documents, identifying populations who are permitted, restricted, or prohibited from taking the medicine.

Absolute Contraindications (Must Not Use)

Category Status
Cefixime Allergy Contraindicated
Severe boldsymbolbeta-Lactam Allergy Contraindicated

Use is absolutely prohibited for patients with a known hypersensitivity to the active ingredient, Cefixime, or any other cephalosporin. Furthermore, the medicine is contraindicated in patients with a history of immediate or severe allergic reactions to penicillins or any other boldsymbolbeta-lactam antibiotic.

Age-Related Eligibility

Safety and effectiveness are not established in infants younger than 6 months of age, meaning use is not recommended for this group. The medicine is approved for use in adults and adolescents. In older adults, use is permitted, but eligibility requires assessment of renal function due to age-related decline.

Conditional Use (Restrictions Apply)

Use is restricted in patients with severe renal impairment (typically Creatinine Clearance le 20 mL/min or those on dialysis); standard use is prohibited. For women who are pregnant or breastfeeding, use is conditional and only permitted if clearly needed, as small amounts may be excreted in human milk. Patients with a history of colitis or seizure disorders are labeled as requiring use with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cefexin (Cefixime) has officially documented interaction patterns that affect the safety and monitoring of co-administered products and diagnostic tests, as specified in government regulatory documents.

Interactions Affecting Drug Exposure and Effect

Co-administration with Warfarin and coumarin-type anticoagulants may enhance the anticoagulant effect, potentially leading to an increased prothrombin time (PT). Patients with renal or hepatic impairment are identified as being at an increased risk for a fall in prothrombin activity during this co-administration.

Simultaneous use with Probenecid is reported to increase the peak serum concentration (Cmax) and AUC of Cefixime by decreasing its renal clearance. Conversely, co-administration with Salicylates may result in a decrease in the plasma exposure of Cefixime. Additionally, elevated plasma levels of Carbamazepine have been reported when taken with Cefixime.

Interactions with Food and Laboratory Tests

Regulatory information notes that the absorption of the Cefixime tablet is not significantly modified by the presence of food, removing an administrative restriction. However, Cefixime causes false-positive reactions with several diagnostic procedures, including the Direct Coombs' test and certain tests for urine sugar (such as Clinitest) and urine ketones (such as the Nitroprusside test). This procedural interaction requires caution in interpreting test results.

Mechanism of Action

Disruption of Bacterial Cell Wall Synthesis

Cefexin functions as a selective covalent inhibitor by interfering directly with the construction of the protective cell wall that surrounds susceptible bacteria. The molecule specifically targets and deactivates Penicillin-Binding Proteins (PBPs)—bacterial enzymes essential for the final cross-linking of the peptidoglycan structure. This action immediately stops the cell from finalizing its protective layer, initiating a molecular cascade that results in the drug's known physiological consequences.


Causal Cascade Leading to Osmotic Lysis

By neutralizing the critical PBP enzymes, Cefixime causes the newly formed bacterial cell wall to be structurally defective and unstable. This failure in cell integrity renders the bacterium unable to withstand its own high internal osmotic pressure, leading inevitably to the cell rupturing and dying (osmotic lysis). This mechanism dictates that the drug induces bacterial cell lysis, resulting in the death of the susceptible bacteria rather than mere inhibition of growth.


Bacterial Mechanism Limitations

The functional application of this mechanism is constrained by the ability of some bacteria to develop resistance. The two primary constraints are the enzymatic destruction of the drug molecule itself by bacterial beta-Lactamases (such as ESBLs), and genetic mutations that alter the structure of the Penicillin-Binding Proteins, thereby reducing the drug's binding affinity and preventing the necessary molecular interaction.

Dosage and Administration Information

How Cefexin is Used

Cefexin (Cefixime) is strictly a prescription-only medication and must be used according to the official instructions provided in the product labeling. The following principles govern its use, based on established prescribing information.

Official Administration and Dosing

Cefexin is approved for oral administration only. The medication can be taken without regard to meals (with or without food).

Feature Standard Instruction
Route of Use Oral (Tablet, Capsule, Oral Suspension)
Adult Dose 400 mg once daily (q24 h) or 200 mg every 12 hours (q12 h)
Frequency Pattern Once or twice daily
Duration Typically 7 to 14 days; a minimum of 10 days is required for infections caused by Streptococcus pyogenes (Group A strep).

Population and Preparation Rules

Certain patient groups require specific dosing adjustments, and the medication form dictates how it must be administered:

  • Pediatric Use: For children 6 months and older, the dose is 8 mg/kg/day, administered as a single dose or divided into two doses (4 mg/kg every 12 hours).
  • Renal Impairment: Dosing must be adjusted based on creatinine clearance (CrCl). For adults with CrCl leq 20 mL/min or those on dialysis, the dose is reduced to 200 mg once daily.
  • Oral Suspension: The liquid suspension form must be shaken well prior to each use and measured precisely with a calibrated dosing tool. The reconstituted suspension must be discarded after 14 days.

Recent Clinical Evidence

Cefexin: Recent Clinical Evidence

Cefexin (also known as Cephalexin) is a first-generation cephalosporin antibiotic that has been widely studied for the treatment of various bacterial infections. Clinical investigations focus on the drug’s utility in treating infections caused by susceptible organisms, primarily Gram-positive bacteria such as Staphylococcus aureus (methicillin-susceptible isolates) and Streptococcus pyogenes.

Therapeutic Focus Areas

Studies have evaluated Cefexin's use across several infection types where oral antibiotic treatment is appropriate. Key areas of investigation include:

  • Skin and Soft Tissue Infections (SSTIs): Research has examined Cefexin's role in treating conditions like cellulitis and non-purulent skin infections. Some trials explore if higher dosing regimens, compared to standard doses, might affect treatment failure rates in complex SSTIs.
  • Respiratory Tract Infections: Clinical application includes treatment for upper and lower respiratory infections, such as pharyngitis and tonsillitis, when caused by susceptible bacteria.
  • Urinary Tract Infections (UTIs): The drug's high excretion rate in the urine has made it a subject of study for treating acute and chronic UTIs caused by organisms like E. coli and P. mirabilis.

Safety and Tolerability Findings

Clinical data evaluated Cefexin's use in short-term treatment. The most frequently documented adverse events reported in clinical trials include diarrhea, nausea, vomiting, and abdominal pain.

Research has indicated that special consideration is given to patients with renal impairment during study protocols, as the drug is primarily eliminated unchanged through the kidneys. Furthermore, studies have recorded the incidence of allergic reactions, including the possibility of cross-reactivity in individuals with known penicillin allergies.

Frequently Asked Questions (FAQ)

Common questions about Cefexin (FAQ)

Q: How quickly does Cefexin usually start to work?

Official pharmacokinetic data indicates that after an oral dose of Cefixime is taken, the drug reaches its peak serum concentration—the highest level in the bloodstream—typically between 2 to 6 hours. This demonstrates how quickly the body absorbs the medicine, but the time it takes for an infection to resolve can vary based on the type and severity of the condition.

Q: What happens if I miss a dose of Cefexin?

According to patient counseling instructions from health authorities, if a dose is missed, the instructions state to take it as soon as you remember. However, if it is almost time for the next scheduled dose, official guidance recommends skipping the missed dose and continuing with the regular schedule. Patients are advised not to take a double dose to make up for a missed one.

Q: Is it normal to feel tired when taking Cefexin?

Adverse event reporting compiled from clinical data has included general disorders such as tiredness (fatigue) and weakness. These are typically reported as being mild in nature, though the official incidence rate may vary. If this symptom is severe or persistent, patients are typically advised to discuss it with their prescribing healthcare provider.

Q: Are there any specific foods or drinks to avoid while using Cefexin?

Regulatory documents state that the absorption of the tablet form of Cefixime is not significantly modified by food, meaning it can generally be taken with or without meals. Specific advice regarding alcohol consumption is often noted as unknown or not established in official labeling. It is important to discuss any specific dietary concerns or questions with a healthcare provider.

Q: Can Cefexin affect birth control pills?

Official information indicates that certain antibiotics, including Cefixime, may decrease the effectiveness of hormonal contraceptives (birth control pills). Patients are advised by official sources to discuss with a healthcare provider whether an alternative or additional method of contraception is necessary during treatment.

Q: Does Cefexin interact with alcohol?

Official drug safety information frequently notes that the interaction between Cefixime and alcohol is unknown or has not been formally established. Discussion with a healthcare provider is the best way to get guidance on alcohol consumption while taking the medication.

Q: What should I do if I think I have an allergic reaction to Cefexin?

Regulatory warnings emphasize that patients who experience any signs of a severe allergic reaction, such as difficulty breathing, swelling of the face or throat, or hives, are advised to seek emergency medical attention immediately. The label information states that the drug should be discontinued at the first sign of any skin hypersensitivity reaction.

Q: What kinds of infections is Cefexin not effective against?

Cefexin is classified as an antibacterial drug, meaning it works by eliminating susceptible bacteria. Official labeling indicates it is not effective for infections caused by viruses, such as the common cold or flu. Furthermore, official information notes that the drug is generally inactive against most anaerobic bacteria and specific resistant organisms like methicillin-resistant Staphylococcus aureus.

Q: What is the general long-term expectation for someone using Cefexin for a chronic condition?

Official labeling states that Cefixime is indicated for the short-term treatment of acute bacterial infections, typically prescribed for durations of 7 to 14 days. Its safety and efficacy have not been formally established for prolonged use in chronic conditions.

Q: Does Cefexin interact with common pain relievers like ibuprofen?

Official documents note a potential interaction risk with Salicylates, which can decrease the amount of Cefixime in the plasma. Healthcare providers may also advise caution when prescribing Cefixime alongside Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) like Ibuprofen, especially in patients who are simultaneously taking anticoagulant medicines like Warfarin.

Q: What is the recommended timeframe for taking Cefexin after an infection is confirmed?

Official guidelines recommend that Cefixime should be used to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. While the label does not specify a precise time window for initiation, it encourages using bacterial culture and susceptibility testing results to select or modify therapy appropriately.

Q: What is the risk of developing a secondary infection (like yeast infection) while on Cefexin?

The use of antibiotics like Cefixime can sometimes lead to the overgrowth of non-susceptible organisms, which is known as superinfection. Official safety reporting has included adverse effects such as vaginal itching or discharge, which may be associated with yeast overgrowth. The more serious documented secondary infection is Clostridium difficile-associated diarrhea (CDAD).

Q: What are the known components of the Cefexin tablet/capsule besides the active ingredient?

In addition to the active ingredient, Cefixime, the medication contains various inactive ingredients known as excipients. These ingredients are necessary for the structure and stability of the product. The complete list of inactive components for each specific dosage form is detailed in the drug’s regulatory labeling.

Q: Why would someone switch from another antibiotic to Cefexin?

Official documentation classifies Cefixime as a third-generation cephalosporin, which has an expanded spectrum of activity against certain Gram-negative bacteria and improved stability against certain bacterial enzymes. These pharmacological advantages are key characteristics that healthcare professionals consider when selecting or switching antibiotic therapy.

Q: Are there different brand names for the medicine Cefexin?

Yes. While the active ingredient is officially named Cefixime, the medicine is marketed under various brand names in different regions, such as Suprax in the US. It is important to confirm with a healthcare provider or pharmacist which product is being dispensed.

Q: What does official guidance say about driving or operating machinery while taking Cefexin?

The official product information notes that Cefixime has been associated with central nervous system effects such as dizziness, confusion, and a rare risk of seizures. Patients are generally advised to exercise caution or avoid driving or operating machinery until they are certain that the medicine does not adversely affect their mental clarity or motor skills.

Q: Is Cefexin considered a controlled substance?

Cefixime is an anti-infective drug. Official listings by government agencies, such as the U.S. Drug Enforcement Administration (DEA), confirm that it is not classified as a federally controlled substance.

Q: Can Cefexin be crushed or split if it is a tablet?

According to the official method of administration, conventional tablets and capsules should generally be swallowed whole. However, specific formulations, such as chewable tablets or scored tablets, may be designed to be chewed or crushed if explicitly stated on the medication’s labeling or directed by a healthcare professional.

Q: Is Cefexin widely used outside of the US?

Yes. Cefixime is globally recognized as an essential medicine. It is included on the World Health Organization's Model List of Essential Medicines and is approved for use by major regulatory bodies throughout Europe (EMA), Canada (Health Canada), and many other international authorities.

Q: What percentage of people report experiencing gastrointestinal side effects with Cefexin?

Official safety documents list gastrointestinal issues, such as diarrhea, as the most common adverse effects. While the exact incidence rate varies across different studies and populations, data from some pediatric trials has reported diarrhea with an incidence of up to 15%.

Q: What are the known drug interactions with over-the-counter supplements?

Regulatory labels generally recommend informing your healthcare provider of all other medications you are taking, including prescription, over-the-counter drugs, vitamins, and herbal products (supplements). This practice allows for the identification of potential drug interactions that may not be specifically detailed in the official Cefixime interaction section.

Q: Is there a generic version of Cefexin available?

Yes. Cefexin is the brand name for the active ingredient, Cefixime. Regulatory listings, such as the FDA’s Orange Book, confirm that the active ingredient, Cefixime, is available from various manufacturers as a generic product.

Q: What does official information say about discontinuing Cefexin early?

Official patient counseling explicitly instructs patients to finish the full prescribed course of Cefixime, even if they begin to feel better. Stopping treatment too soon increases the risk that the infection may return and contributes to the potential development of drug-resistant bacteria.

Q: Is Cefexin used to prevent infections?

Official labeling indicates that Cefixime is indicated for the treatment of infections that are proven or strongly suspected to be caused by susceptible bacteria. Regulatory bodies advise against its use to prevent infections in the absence of a proven or suspected bacterial cause, as this misuse can increase the risk of developing drug resistance.

Q: How long does Cefexin stay in the body after the last dose?

The drug’s elimination rate is measured by its half-life, which is the time required for half of the drug to be eliminated from the body. Official pharmacokinetic data shows that the average elimination half-life of Cefixime in adults with normal kidney function ranges from 2.4 to 4 hours.

How should Cefexin be stored and disposed of?

How to Store and Dispose of Cefexin (Cefixime)

Cefixime must be stored and handled according to specific regulatory requirements to maintain its stability and effectiveness.

Storage Conditions

Oral solids and the powder for suspension must be kept at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medication must be kept in the original container and the container must remain tightly closed.

For the liquid suspension, once reconstituted, it is stable for 14 days when stored at Controlled Room Temperature or under refrigeration (2 C to 8 C). The reconstituted liquid must not be frozen.

All forms of Cefixime must be stored out of the reach of children.

Disposal Instructions

Expired or unused Cefixime should be disposed of in accordance with local regulations, often utilizing a medicine take-back program. The product should not be flushed down the toilet or discarded in wastewater unless the specific labeling directs otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefexin found in:

A-Z Index: